Huazhong University Of Science And Technology
Clinical trials sponsored by Huazhong University Of Science And Technology, explained in plain language.
-
New hope for advanced colon cancer: drug cocktail plus radiation tested
Disease control Not yet recruitingThis study is for people with metastatic colorectal cancer that has spread to a few spots (like the liver or lungs) and hasn't responded to at least two prior treatments. It tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) plus targeted radiation to the…
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
New drug shows promise for stuffy nose condition that Won't go away
Disease control Not yet recruitingThis study tests whether the drug Stapokibart (CM310) can reduce nasal symptoms in adults with Non-Allergic Rhinitis with Eosinophilia Syndrome (NARES), a chronic condition causing congestion and runny nose not due to allergies. About 90 participants will receive either the drug …
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New triple therapy shows promise for hard-to-treat stomach cancer
Disease control Not yet recruitingThis study is for people with advanced HER2-negative stomach or gastroesophageal junction cancer that cannot be removed by surgery. It tests a new approach: giving a special type of radiotherapy followed by a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) p…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
AI or drug: which keeps weight off better in type 2 diabetes?
Disease control Not yet recruitingThis study tests whether an AI-guided lifestyle program can help adults with type 2 diabetes and overweight or obesity maintain weight loss as well as or better than continuing the drug tirzepatide. All 400 participants first receive tirzepatide for 20 weeks to lose weight, then …
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New painkiller may cut opioid use after shoulder surgery
Symptom relief Not yet recruitingThis study tests if a long-acting pain medicine (liposomal bupivacaine) works better than standard bupivacaine for numbing nerves around the shoulder after arthroscopic surgery. About 60 adults aged 18-60 having shoulder surgery will receive one of the two medicines via ultrasoun…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 17, 2026 06:48 UTC
-
Zapping away shingles pain: new brain stimulation trial offers hope
Symptom relief Not yet recruitingThis study tests a non-invasive brain stimulation technique to reduce pain in people with postherpetic neuralgia, a chronic nerve pain condition that can follow shingles. About 94 adults with moderate to severe pain will receive either real or sham (fake) stimulation to see if th…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Can tiny acupuncture needles cure menopausal insomnia?
Symptom relief Not yet recruitingThis study tests if small acupuncture-like needles (thumbtack needles) can help women going through menopause who have trouble sleeping. About 198 women will be split into two groups: one gets the real needles, the other gets fake needles. The treatment lasts 4 weeks, and researc…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New painkiller aims to cut opioid use after abdominal surgery
Symptom relief Not yet recruitingThis study tests whether a long-acting numbing drug (bupivacaine liposomes) can reduce pain and the need for opioid painkillers after laparoscopic liver, gallbladder, or pancreas surgery. About 60 adults will receive either the long-acting drug mixed with a standard numbing drug …
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
Acupuncture may boost IVF success in women with repeated failure
Symptom relief Not yet recruitingThis study tests whether acupuncture can increase pregnancy rates in women who have had multiple failed embryo transfers. Researchers will compare pregnancy outcomes between women receiving acupuncture and those who do not. The trial involves 208 participants aged 20-40 who are p…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC
-
New test could warn of pancreatic Cancer's return
Knowledge-focused Not yet recruitingThis study looks at whether tumor cells found in the portal vein (a major liver blood vessel) can help predict if pancreatic cancer will come back or spread after surgery. Researchers will collect these cells during an endoscopic ultrasound and combine them with other tests. The …
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 17, 2026 07:06 UTC
-
Can we predict dangerous side effects of immunotherapy?
Knowledge-focused Not yet recruitingThis study aims to find biological markers (biomarkers) that can predict serious side effects caused by immune checkpoint inhibitor drugs, which are used to treat cancer. Researchers will collect data from 440 adults starting these drugs for the first time and track them for side…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
AI tool design could make or break doctor adoption
Knowledge-focused Not yet recruitingThis study looks at how different features of an AI system that helps doctors make decisions affect whether they actually use it. About 3,000 primary care doctors in China will test 32 different versions of an AI tool for diagnosing respiratory infections. The goal is to find out…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC
-
Million-Person study to unlock secrets of chinese medicine for modern diseases
Knowledge-focused Not yet recruitingThis study will follow one million adults aged 30-74 in Hubei, China, for up to 10 years. Researchers will collect health data and Traditional Chinese Medicine (TCM) body types to see how they relate to chronic diseases like heart disease, cancer, and diabetes. The goal is to cre…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC